NCT03915678
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03915678
Title Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors (AGADIR)
Acronym AGADIR
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut Bergonie
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Institut Bergonié Bordeaux 33076 France Details
Chu Brest Brest 29200 France Details
Centre François Baclesse Caen 14076 France Details
Centre Georges François Leclerc Dijon 21079 France Details
Centre Oscar Lambret Lille 59020 France Details
Hôpital La Timone Marseille 13005 France Details
Institut Paoli Calmettes Marseille 13273 France Details
Institut Curie Paris 75005 France Details
CHU Poitiers Poitiers 86000 France Details
Centre Eugène Marquis Rennes 35042 France Details
IUCT Oncopôle Toulouse 31052 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field